InvaGen Pharmaceuticals is laying off 205 employees across two New York facilities. The job cuts are scheduled to begin on November 27. This decision is part of a broader cost-reduction strategy by its parent company, Cipla. The layoffs are also influenced by economic pressures and supply chain realignments affecting generic dr-g manufacturers. Despite the layoffs, Cipla will continue its U.S. operations.
New York
https://whatnow.com/new-york/local-news/leading-pharmaceutical-company-to-lay-off-205-employees-across-two-new-york-facilities/